Launched today at the European Parliament in Brussels in the presence of EU Health Commissioner Markos Kyprianou and Dr Nata Menabde, Deputy Regional Director of WHO Europe, the Charter is an impressive EU-wide policy document on cardiovascular disease prevention. It is signed by 14 eminent professional and public health organisations and will change the way Europe tackles CVD.
Governments, NGOs and health organisations that sign the charter commit to reduce considerably the burden of CVD in Europe (reducing the numbers of smokers, promoting healthy food choices and physical activity, reducing obesity rates and implementing best practices in cardiovascular care). They pledge to launch public information campaigns and to work towards implementing public policy that improves cardiovascular health, such as promoting exercise in schools and smoking bans. All signatories agree to strive for equity in treatment within their country and across Europe.
EU Health Commissioner Markos Kyprianou said: "The European Commission is very pleased to have been able to play a part in bringing the Charter into being. If we are going to beat cardiovascular disease we need to redouble our efforts. We need concerted action by governments together with the health sector, with business and with NGOs and –most importantly- with citizens".
The Charter provides national governments, NGOs and health organisations with a series of tools, including HeartScore, that will help them highlight the dangers of heart disease and create awareness amongst the general population. This can all be found on a dedicated web site (www.heartcharter.eu), which contains information about how the Charter is being implemented and aims to be a platform for exchange and successful interventions. It hosts also translations of the charter in 18 languages and examples of print and television advertisements that can be adapted for different markets.
European Heart Network Director Susanne Løgstrup said she firmly believes the Charter will improve the health of Europeans.
“It is my view, that the European Heart Health Charter will bring a new dynamic to the way in which the EU – and indeed European - health policy is developed and implemented,” she said. “I am confident that with the support of the European Commission, WHO European Region and with the commitment and skill provided by the signatories, representing leading European health organisations and professional societies, in 10 years time Europe will be a healthier place with a healthier population. And that is good for everybody.”
European Society of Cardiology Past President and Co-Chair of the Charter Steering Committee Lars Rydén believes the Charter’s emphasis on prevention will help reduce the burden of CVD across Europe.
“Until recently the focus of attention has been on treatment. This means extending the lives of people already affected and society has ended up accumulating a mountain of people who are ill,” he said. “What we have to concentrate on now is prevention, which is the goal of the Charter. We cannot continue to create a society that makes people ill, and then invest a lot of money in curing them.”
The Charter encourages participants to pay attention to gender-specific aspects of cardiovascular health and disease, and will have a specific goal of educating and supporting the younger population so they will practice heart-healthy activities throughout their lives. The Charter calls for research on the effectiveness of policy and preventive interventions, including aspects of health care expenditures as well as for epidemiological and behavioural research to determine the factors that affect the heart. Special attention will be given to the young, and towards understanding the mechanisms of ageing in the cardiovascular system.
“The Charter on CVD in Europe has the full support of both WHO and the European Commission,” said Dr. Jill Farrington, Noncommunicable Disease Coordinator of WHO Regional Office for Europe. “It provides a clear message that WHO and the European Commission are working hand in hand with cardiologists from the ESC and public organisations from EHN to form a strong, visible alliance against Europe’s greatest killer.”
It is imperative that politicians create policies that support prevention of CVD. A primary goal of the Charter is to improve our lifestyles. Better use of available treatment is also mandatory among those already afflicted by CVD.
“Changing lifestyle is not a matter of the individual alone. For people to change their lifestyle, they need supportive environments. All EU policy areas need to work in concert to create these healthier environments for all European citizens,” said Dr. Georgs Andrejevs, member of the European Parliament. “Inequalities in mortality CVD do not only occur between countries, but also within countries. Inequalities in mortality from CVD account for almost half of the excess mortality in lower socio-economic groups in most countries. Examples of inequalities can be given in the field of obesity, availability of healthy food and smoking. The Charter addresses these issues.”
“The Charter is ultimately an initiative to change European law,” said Professor John Martin, Co-Chair of the ESC Committee for European Union Relations. “If you believe that Europe has a future by giving up sovereignty to the greater good then this is one way of manifesting it – the most concrete way of doing that.”
ESC Press Office | alfa
How cancer metastasis happens: Researchers reveal a key mechanism
19.01.2018 | Weill Cornell Medicine
Researchers identify new way to unmask melanoma cells to the immune system
17.01.2018 | Duke University Medical Center
On the way to an intelligent laboratory, physicists from Innsbruck and Vienna present an artificial agent that autonomously designs quantum experiments. In initial experiments, the system has independently (re)discovered experimental techniques that are nowadays standard in modern quantum optical laboratories. This shows how machines could play a more creative role in research in the future.
We carry smartphones in our pockets, the streets are dotted with semi-autonomous cars, but in the research laboratory experiments are still being designed by...
What enables electrons to be transferred swiftly, for example during photosynthesis? An interdisciplinary team of researchers has worked out the details of how...
For the first time, scientists have precisely measured the effective electrical charge of a single molecule in solution. This fundamental insight of an SNSF Professor could also pave the way for future medical diagnostics.
Electrical charge is one of the key properties that allows molecules to interact. Life itself depends on this phenomenon: many biological processes involve...
At the JEC World Composite Show in Paris in March 2018, the Fraunhofer Institute for Laser Technology ILT will be focusing on the latest trends and innovations in laser machining of composites. Among other things, researchers at the booth shared with the Aachen Center for Integrative Lightweight Production (AZL) will demonstrate how lasers can be used for joining, structuring, cutting and drilling composite materials.
No other industry has attracted as much public attention to composite materials as the automotive industry, which along with the aerospace industry is a driver...
Scientists at Tokyo Institute of Technology (Tokyo Tech) and Tohoku University have developed high-quality GFO epitaxial films and systematically investigated their ferroelectric and ferromagnetic properties. They also demonstrated the room-temperature magnetocapacitance effects of these GFO thin films.
Multiferroic materials show magnetically driven ferroelectricity. They are attracting increasing attention because of their fascinating properties such as...
08.01.2018 | Event News
11.12.2017 | Event News
08.12.2017 | Event News
19.01.2018 | Materials Sciences
19.01.2018 | Health and Medicine
19.01.2018 | Physics and Astronomy